10.96% Abbott Laboratories shares are trading close to a resistance zone which currently limits any upside potential. We expect that this level will be broken due to the stock's technical chart pattern. Investors have an opportunity to buy the stock and target the $ 125. Summary The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria. The company has solid fundamentals for a short-term investment strategy. Strengths Over the past year, analysts have regularly revised upwards their sales forecast for the company. Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.